Key Takeaways Combination Therapy Preserves Muscle Mass: Regenerons semaglutide plus trevogrumab combo significantly preserved lean muscle mass in patients with obesity, improving on the muscle loss typically seen with GLP-1 monotherapy
This week, Eli Lilly posted the first large-scale trial results of its experimental combination drug retatrutideand its a whopper of a success
L- , ,
Starting in July, Medicare will also cover these drugs for more people: If your body mass index (BMI) is 30 or higher, and you have: Heart failure High blood pressure that isnt controlled Moderate to severe kidney disease Or if your BMI is 27 or higher, and you have: Prediabetes and heart disease Commercial and employer-sponsored insurance If you have commercial or employer insurance, you may qualify for a savings card that can lower your cost to about $25 a month
The GKV-Beitragssatzstabilisierungsgesetz, currently advancing through parliament with most provisions effective January 1, 2027, contains no provision to reclassify obesity treatments
Not for human or animal use, diagnosis, or treatment